Comparative study of reference points by dosimetric analyses for late complications after uniform external radiotherapy and high-dose-rate brachytherapy for cervical cancer

被引:27
作者
Chen, SW
Liang, JA
Yeh, LS
Yang, SN
Shiau, AC
Lin, FJ
机构
[1] China Med Univ, Sch Med, Dept Radiat Therapy, Taichung, Taiwan
[2] China Med Univ, Sch Med, Dept Oncol, Taichung, Taiwan
[3] China Med Univ, Sch Med, Dept Obstet & Gynecol, Taichung, Taiwan
[4] Natl Taiwan Univ, Sch Med, Taipei, Taiwan
[5] Shin Kong Mem Hosp, Dept Radiat Therapy & Oncol, Taipei, Taiwan
来源
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2004年 / 60卷 / 02期
关键词
cervical cancer; brachytherapy; late sequelae; radiation dose;
D O I
10.1016/j.ijrobp.2004.05.028
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: This study aimed to correlate and compare the predictive values of rectal and bladder reference doses of uniform external beam radiotherapy without shielding and high-dose-rate intracavitary brachytherapy (HDRICB) with late sequelae in patients with uterine cervical cancer. Methods and Materials: Between September 1992 and December 1998, 154 patients who survived more than 12 months after treatment were studied. Initially, they were treated with 10-MV X-rays (44 to 45 Gy/22 to 25 fractions over 4 to 5 weeks) to the whole pelvis, after which HDRICB was performed using Ir-192 remote afterloading at 1-week intervals for 4 weeks. The standard prescribed dose for each HDRICB was 6.0 Gy to point A. Patient- and treatment-related-factors were evaluated for late rectal complications using logistic regression modeling. Results: The probability of rectal complications showed better correlation of dose-response with increasing total ICRU (International Committee on Radiotherapy Units and Measurements) rectal dose. Multivariate logistic regression demonstrated a high risk of late rectal sequelae in patients who developed rectal complications (p = 0.0001;relative risk, 15.06;95% CI, 2.89-43.7) and total ICRU rectal dose greater than 16 Gy (p = 0.02;relative risk, 2.07;95% CI, 1.13-4.55). The high risk factors for bladder complications were seen in patients who developed rectal complications (p = 0.0001;relative risk, 15.2;95% CI, 2.81similar to44.9) and total ICRU bladder dose greater than 24 Gy (p = 0.02;relative risk, 8.93;95% CI, 1.79similar to33.1). Conclusion: This study demonstrated the predictive value of ICRU rectal and bladder reference dosing in HDRICB for patients receiving uniform external beam radiation therapy without central shielding. Patients who had a total ICRU rectal dose greater than 16 Gy, or a total ICRU bladder dose over 24 Gy, were at risk of late sequelae. (C) 2004 Elsevier Inc.
引用
收藏
页码:663 / 671
页数:9
相关论文
共 31 条
[1]   HIGH-DOSE-RATE INTRACAVITARY IRRADIATION IN THE TREATMENT OF CARCINOMA OF THE UTERINE CERVIX - EARLY EXPERIENCE WITH 84 PATIENTS [J].
AKINE, Y ;
ARIMOTO, H ;
OGINO, T ;
KAJIURA, Y ;
TSUKIYAMA, I ;
EGAWA, S ;
YAMADA, T ;
TANEMURA, K ;
TSUNEMATSU, R ;
OHMI, K ;
SONODA, T ;
KASAMATSU, T .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1988, 14 (05) :893-898
[2]   HIGH-DOSE-RATE AFTERLOADING TECHNIQUE IN THE RADIATION TREATMENT OF UTERINE CERVICAL-CANCER - 399 CASES AND 9 YEARS EXPERIENCE IN TAIWAN [J].
CHEN, MS ;
LIN, FJ ;
HONG, CH ;
TU, CP ;
LAN, JH ;
TANG, SG ;
LEUNG, WM ;
WANG, TR .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1991, 20 (05) :915-919
[3]   The prediction of late rectal complications following the treatment of uterine cervical cancer by high-dose-rate brachytherapy [J].
Chen, SW ;
Liang, JA ;
Yang, SN ;
Liu, RT ;
Lin, FJ .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2000, 47 (04) :955-961
[4]   Unique role of proximal rectal dose in late rectal complications for patients with cervical cancer undergoing high-dose-rate intracavitary brachytherapy [J].
Cheng, JCH ;
Peng, LC ;
Chen, YH ;
Huang, DYC ;
Wu, JK ;
Jian, JJM .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2003, 57 (04) :1010-1018
[5]   RECTAL COMPLICATIONS IN PATIENTS WITH CARCINOMA OF THE CERVIX TREATED WITH CONCOMITANT CISPLATIN AND EXTERNAL-BEAM IRRADIATION WITH HIGH-DOSE-RATE BRACHYTHERAPY - A DOSIMETRIC ANALYSIS [J].
CLARK, BG ;
SOUHAMI, L ;
ROMAN, TN ;
EVANS, MDC ;
PLA, C .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1994, 28 (05) :1243-1250
[6]   The prediction of late rectal complications in patients treated with high dose-rate brachytherapy for carcinoma of the cervix [J].
Clark, BG ;
Souhami, L ;
Roman, TN ;
Chappell, R ;
Evans, MDC ;
Fowler, JF .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1997, 38 (05) :989-993
[7]   TOXICITY CRITERIA OF THE RADIATION-THERAPY ONCOLOGY GROUP (RTOG) AND THE EUROPEAN-ORGANIZATION-FOR-RESEARCH-AND-TREATMENT-OF-CANCER (EORTC) [J].
COX, JD ;
STETZ, J ;
PAJAK, TF .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1995, 31 (05) :1341-1346
[8]   DOSE-VOLUME ANALYSIS AND THE PREVENTION OF RADIATION SEQUELAE IN CERVICAL-CANCER [J].
CROOK, JM ;
ESCHE, BA ;
CHAPLAIN, G ;
ISTURIZ, J ;
SENTENAC, I ;
HORIOT, JC .
RADIOTHERAPY AND ONCOLOGY, 1987, 8 (04) :321-332
[9]   HIGH-DOSE-RATE BRACHYTHERAPY FOR CARCINOMA OF THE CERVIX - HIGH TECH OR HIGH-RISK [J].
EIFEL, PJ .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1992, 24 (02) :383-386
[10]   Patterns of radiotherapy practice for patients with squamous carcinoma of the uterine cervix: Patterns of care study [J].
Eifel, PJ ;
Moughan, J ;
Owen, J ;
Katz, A ;
Mahon, I ;
Hanks, GE .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1999, 43 (02) :351-358